메뉴 건너뛰기




Volumn 3, Issue 4, 2000, Pages 167-171

The gap between knowledge and practice in the treatment and prevention of cardiovascular disease

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYPOCHOLESTEROLEMIC AGENT; WARFARIN;

EID: 0033769272     PISSN: 1520037X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1520-037X.2000.80381.x     Document Type: Review
Times cited : (6)

References (60)
  • 1
    • 0030808080 scopus 로고    scopus 로고
    • Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
    • (1997) Am Heart J , vol.133 , pp. 703-712
    • Massie, B.M.1    Shah, N.B.2
  • 2
    • 85019316271 scopus 로고
    • Effects of enalapril on mortality in severe congestive heart failure
    • (1987) N Engl J Med , vol.316 , pp. 1430-1435
  • 5
    • 0032565601 scopus 로고    scopus 로고
    • Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995
    • (1998) Arch Intern Med , vol.158 , pp. 1074-1080
    • Smith, N.L.1    Psaty, B.M.2    Pitt, B.3
  • 7
    • 0019459311 scopus 로고
    • Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
    • (1981) N Engl J Med , vol.304 , pp. 801-807
  • 8
    • 0019519095 scopus 로고
    • The beta-blocker heart attack trial (BHAT)
    • (1981) JAMA , vol.246 , pp. 2073-2074
  • 9
    • 4243330779 scopus 로고
    • The Goteborg Metoprolol Trial in Acute Myocardial Infarction
    • (1984) Am J Cardiol , vol.53
  • 11
    • 0028339758 scopus 로고
    • Impact of clinical trials on the use of beta blockers after acute myocardial infarction and its relation to other risk indicators for death and 1-year mortality rate
    • (1994) Clin Cardiol , vol.17 , pp. 311-316
    • Karlson, B.W.1    Herlitz, J.2    Hjalmarson, A.3
  • 13
  • 16
    • 0027505093 scopus 로고
    • Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke
    • (1993) Lancet , vol.342 , pp. 1256-1262
  • 17
    • 0028244264 scopus 로고
    • Atrial fibrillation: Risk factors for embolization and efficacy of antithrombotic therapy
    • (1994) Arch Intern Med , vol.154 , pp. 1449-1457
  • 19
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival study (4S)
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 23
    • 0023930868 scopus 로고
    • Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
    • (1988) Arch Intern Med , vol.148 , pp. 36-69
  • 34
    • 0028911563 scopus 로고
    • Relationship of dietary intake to hospital admission for coronary heart and vascular disease: The NHANES II national probability study
    • (1995) J Am Coll Nutr , vol.14 , pp. 71-79
    • Gartside, P.S.1    Glueck, C.J.2
  • 35
    • 0028911563 scopus 로고
    • The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalizations and mortality: The prospective NHANES I follow-up study
    • (1995) J Am Col Nutr , vol.14 , pp. 71-79
    • Gartside, P.S.1    Glueck, C.J.2
  • 36
    • 0027243348 scopus 로고
    • Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
    • (1993) JAMA , vol.269 , pp. 3015-3023
  • 37
    • 0029886630 scopus 로고    scopus 로고
    • Blood pressure as a cardiovascular risk factor
    • (1996) JAMA , vol.275 , pp. 1571-1576
    • Kannel, W.B.1
  • 42
    • 0030711521 scopus 로고    scopus 로고
    • Trends in antihypertensive drug use in the United States: Do the JNC V recommendations affect prescribing?
    • (1997) JAMA , vol.278 , pp. 1745-1748
    • Siegel, D.1    Lopez, J.2
  • 43
    • 0027399060 scopus 로고
    • The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
    • (1993) Arch Intern Med , vol.153 , pp. 154-183
  • 44
    • 0030713021 scopus 로고    scopus 로고
    • The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    • (1997) Arch Intern Med , vol.157 , pp. 2413-2444
  • 46
    • 0007547195 scopus 로고
    • National Center for Heart Statistics. Prevalence of selected chronic conditions, United States, 1986-88. Vital and Health Statistics. DHHS publication no. (PHS) 93-1510. Washington, DC: U.S. Government Printing Office
    • (1993)
    • Collins, J.G.1
  • 47
    • 0020078179 scopus 로고
    • A randomized trial of propanolol in patients with acute myocardial infarction. I. Mortality results
    • (1982) JAMA , vol.247 , pp. 1707-1714
  • 48
    • 0030574221 scopus 로고    scopus 로고
    • Re-examining the clinical safety and roles of calcium antagonists in cardiovascular medicine
    • (1996) Am J Cardiol , vol.78 , Issue.SUPPL. 9A , pp. 13-18
    • Conti, C.R.1
  • 51
    • 0030841670 scopus 로고    scopus 로고
    • Is the calcium antagonist debate having an effect on clinical practice?
    • (1997) Am J Cardiol , vol.79 , Issue.10 A , pp. 20-23
    • Hobbs, F.D.R.1
  • 56
    • 0030711523 scopus 로고    scopus 로고
    • JNC guidelines: Is the message getting through?
    • (1997) JAMA , vol.278 , pp. 1178-1179
    • Lenfant, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.